Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
about
Role of multiparametric magnetic resonance imaging in early detection of prostate cancerAssessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer.Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.ProstateAnalyzer: Web-based medical application for the management of prostate cancer using multiparametric MR imaging.Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR ImagingProstate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance ImagingPerformance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 268Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.Is contrast enhancement needed for diagnostic prostate MRI?Evaluating the Role of mpMRI in Prostate Cancer Assessment.A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study.68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.Detection of prostate cancer using magnetic resonance imaging/ultrasonography image-fusion targeted biopsy in African-American men.Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancerStandardization of multiparametric prostate MR imaging using PI-RADS.Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.Dynamic contrast-enhanced MRI of the prostate with high spatiotemporal resolution using compressed sensing, parallel imaging, and continuous golden-angle radial sampling: preliminary experience.Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth.Diagnostic Accuracy of Magnetic Resonance Imaging (MRI) 5-Point Likert Scoring System Evaluated by The Result of MRI/Ultrasonography Image-fusion Targeted Biopsy of The Prostate.Information of prostate biopsy positive core: does it affect MR detection of prostate cancer on using 3T-MRI?Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 Tesla.Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology.Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB.
P2860
Q26768765-E71238E9-0DC5-4E04-AC6D-DFE1E3B1EEF5Q30843143-8E280EB3-A8BE-48B0-ADA5-17F151088E6DQ31137158-56389255-2437-413E-9704-AAE4C53E3472Q35566952-7B477AC2-E7F9-4700-A511-3CD507B7BDFCQ35670525-76BFEA40-3907-4326-A355-085247809399Q36049175-B875366F-DF89-4EF7-A9EA-FC71C0D4DE5BQ36084787-72B8C4E4-C6C3-4699-A14F-5F457364AB16Q36100707-CCDAA0F7-F11D-4D99-A5FE-3B853180A4A0Q36140880-808328F8-AC9F-4A56-82DB-144E9E1C5B24Q37707083-14F5E9D1-0706-49C4-AD89-510917EAD165Q38541412-82C9CF01-3561-40AA-A190-EB4B384E9CC8Q38671168-ECBC67E0-F57A-4C52-AAE3-C301257F9A34Q38675322-C44CFEBA-F149-430A-8796-D6CB5B9E1CD0Q38705859-8AA22AEB-3CD4-4FCE-A729-E528344E502EQ38806269-8946E0A4-F572-4A52-B01C-3C7C24C5FEAAQ38895102-DC1B1835-9400-43D7-AD25-37CCE86EC6CCQ38925342-927F41EB-B76B-4088-9E3A-C740618AA1F5Q40330198-F95852AC-B7B2-400E-A053-3F53E64C7AD0Q40368959-3B6F956A-730D-4BFF-A8A6-39961F7F14E6Q40487460-683334CB-1B9E-41D2-9214-388DA7E3E2B1Q41161482-F114E7D6-96FC-43FE-923A-29973A4B7FCBQ41214926-F30F35C9-EEAF-461F-A746-DD225BAB121FQ42145310-43E4EC99-8F34-422A-90E4-32D3396B0D8EQ42373209-2613F410-ECFE-4B26-80BF-E18C3CCF2865Q42375733-0D3CB293-4A40-419E-BFDC-9FE8015C03E0Q44688793-6A456756-3BCA-4036-8161-B607227AC794Q50047697-240E2C8A-AE13-4923-AC96-780DE38D7495Q51010281-48392104-2710-43E2-88CD-7D1BC3ED8CB9Q53064739-6665A13A-CA50-4A99-A471-B2170D00F2E7Q53669010-4C048A57-8951-435C-863C-0E1484176666Q55385233-5A151AD3-8021-4BAE-AE5F-192696671F74
P2860
Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@en
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@nl
type
label
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@en
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@nl
prefLabel
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@en
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@nl
P2093
P2860
P1433
P1476
Evaluation of the ESUR PI-RADS ...... on-guided biopsy at 3.0 Tesla.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00330-013-3017-5
P407
P577
2013-10-03T00:00:00Z